What is proton therapy, and what cancers can it treat?

Written by: Dr Crispin Hiley
Published:
Edited by: Conor Lynch

In this article below, highly regarded and experienced consultant clinical oncologist, Dr Crispin Hiley, provides us with an insightful guide on proton therapy, including how it benefits patients with lung cancer, and the potential side effects patients receiving the therapy may experience.

What is proton therapy?

It is a type of radiotherapy, given each day in small doses. It differs from conventional radiotherapy as it is a slghly different particle. This has some benefits. There are not as many side effects related to proton therapy as there are associated with conventional radiotherapy. Essentially, proton therapy reduces the side effects caused by radiotherapy.

 

What types of cancer can be treated with proton therapy?

Proton therapy is recommended in cancers where it is critical to reduce the side effects associated with the treatment of those cancers. Proton therapy is effective for paediatric cancer, or for patients who have cancers at the base of the skull.

 

Common cancers that are treated with proton therapy nowadays include:

 

  • head and neck cancers
  • breast cancer
  • certain types of lung cancer

 

What are the potential side effects of proton therapy?

Fatigue, cough, and problems with swallowing are all potential side effects.

 

When is proton therapy indicated for patients with lung cancer?

Proton therapy is very effective when it comes to treating non-small cell lung cancer, with early lung cancers, as well as patients with locally advanced lung cancers. It can also be useful for patients with mesothelioma, and also for patients who need radiotherapy following surgery for an enlargement of the thymic gland in the front part of the chest.

 

 

If you would like to book a consultation with Dr Crispin Hiley, you can do so via his Top Doctors profile here today

By Dr Crispin Hiley
Clinical oncology

Dr Crispin Hiley is a highly reputable and skilled consultant clinical oncologist who currently practises at the London-based Cromwell Hospital. He is also an associate professor in clinical oncology at University College London. 

Dr Hiley specialises in all the different kinds of lung cancer and also possesses a significant amount of expertise in chemotherapy, cancer immunotherapy, radiotherapy, proton beam therapy, as well as mesothelioma, amongst many others. He is, at present, the chief investigator or principle investigator for several academic and industry clinical trials relating specifically to lung cancer, and also leads a radiation therapy-focused research group at the University College London Cancer Institute. He has been involved in writing the RCR Lung Cancer Consensus Guidelines that establish best practice for the managment of lung cancers with radiotherapy. 

Dr Hiley is also an expert in stereotactic radiotherapy (SABR) for patients with oligometastatic cancers. These are cancers that have spread to different areas (usually less than five) where SABR in combination with other cancer treatments can be used to help control the cancer. SABR can be used to treat many different cancer types e.g. lung, breast colorectal and prostate which have become oligometastatic.

Dr Hiley graduated with honours in medicine in 2005 at the University of Manchester, before going on to undertake training across the UK and abroad, at highly established hospitals such as the MD Anderson Cancer Centre, Houston, in the USA, as well as the King's College London, but to name a few. He has, to-date, published a significantly high number of articles in some of the world's most prestigious journals, including The Lancet. He is the clinical lead and lung proton therapy lead of the University College London Hospital clinical oncology lung team, and is also the current deputy lead of clinical trials for the CRUK Lung Cancer Centre of Excellence. Dr Hiley is available for second opinions. 

View Profile

Overall assessment of their patients


  • Related procedures
  • Prostate cancer
    Breast cancer
    Bone cancer
    Nervous system malformations
    Brain tumour
    Bone marrow cancers
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Neuro-oncology
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.